Scientists discover, test new class of pain relievers

A potential new class of small-molecule drugs has been discovered that simultaneously inhibit two sought-after targets in the treatment of pain, the ion channels TRPV4 and TRPA1. Their proof-of-concept experiments in mice could lead to the development of a new drug to treat conditions including skin irritation, headaches, jaw pain and abdominal pain.